Lidocaine vaginal gel: Phase II started

Juniper began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate a single dose of 150 mg COL-1077 in 150 patients undergoing pipelle-directed endometrial biopsy with tenaculum placeme...